Global NSAIDs for Dysmenorrhea Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Diclofenac, ibuprofen, ketoprofen, meclofenamate, mefenamic acid, and naproxen are the NSAIDs specifically approved by the US Food and Drug Administration (FDA) for treatment of dysmenorrhea.
The NSAIDs for Dysmenorrhea market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global NSAIDs for Dysmenorrhea market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The NSAIDs for Dysmenorrhea market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Hospital occupied for % of the NSAIDs for Dysmenorrhea global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Ibuprofen segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of NSAIDs for Dysmenorrhea include IOLCP, Granules Biocause, Strides Shasun, BASF and SI Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global NSAIDs for Dysmenorrhea market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main NSAIDs for Dysmenorrhea manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global NSAIDs for Dysmenorrhea market based on the following parameters – headquarters, production locations, products portfolio, NSAIDs for Dysmenorrhea revenue, sales, average price and gross margin, recent developments.
Evaluation and forecast the NSAIDs for Dysmenorrhea market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
NSAIDs for Dysmenorrhea market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Chapter 1, to describe NSAIDs for Dysmenorrhea product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of NSAIDs for Dysmenorrhea, with price, sales, revenue and global market share of NSAIDs for Dysmenorrhea from 2019 to 2022.
Chapter 3, the NSAIDs for Dysmenorrhea competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NSAIDs for Dysmenorrhea breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and NSAIDs for Dysmenorrhea market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of NSAIDs for Dysmenorrhea.
Chapter 13, 14, and 15, to describe NSAIDs for Dysmenorrhea sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The NSAIDs for Dysmenorrhea market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global NSAIDs for Dysmenorrhea market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The NSAIDs for Dysmenorrhea market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Hospital occupied for % of the NSAIDs for Dysmenorrhea global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Ibuprofen segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of NSAIDs for Dysmenorrhea include IOLCP, Granules Biocause, Strides Shasun, BASF and SI Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global NSAIDs for Dysmenorrhea market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main NSAIDs for Dysmenorrhea manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global NSAIDs for Dysmenorrhea market based on the following parameters – headquarters, production locations, products portfolio, NSAIDs for Dysmenorrhea revenue, sales, average price and gross margin, recent developments.
Evaluation and forecast the NSAIDs for Dysmenorrhea market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
NSAIDs for Dysmenorrhea market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
- Ibuprofen
- Celecoxib
- Ketoprofen
- Others
- Hospital
- Clinic
- Pharmacy
- Other
- IOLCP
- Granules Biocause
- Strides Shasun
- BASF
- SI Group
- Hisoar
- Pfizer Inc
- Teva
- Mylan
- Apotex
- Lupin
- SANOFI-Aventis
- Boehringer-Ingelheim
- BEC Chemicals
- Shandong Xinhua Pharmaceutical
- Hengrui Medicine
- Hubei Biocause Heilen Pharmaceutical
- Zibo Xinhua-PERRIGO Pharmaceutical
- Zhejiang Jiuzhou
- Hubei Xunda
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe NSAIDs for Dysmenorrhea product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of NSAIDs for Dysmenorrhea, with price, sales, revenue and global market share of NSAIDs for Dysmenorrhea from 2019 to 2022.
Chapter 3, the NSAIDs for Dysmenorrhea competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NSAIDs for Dysmenorrhea breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and NSAIDs for Dysmenorrhea market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of NSAIDs for Dysmenorrhea.
Chapter 13, 14, and 15, to describe NSAIDs for Dysmenorrhea sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 NSAIDs for Dysmenorrhea Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global NSAIDs for Dysmenorrhea Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Ibuprofen
1.2.3 Celecoxib
1.2.4 Ketoprofen
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global NSAIDs for Dysmenorrhea Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global NSAIDs for Dysmenorrhea Market Size & Forecast
1.4.1 Global NSAIDs for Dysmenorrhea Sales in Value (2017 & 2021 & 2028)
1.4.2 Global NSAIDs for Dysmenorrhea Sales in Volume (2017-2028)
1.4.3 Global NSAIDs for Dysmenorrhea Price (2017-2028)
1.5 Global NSAIDs for Dysmenorrhea Production Capacity Analysis
1.5.1 Global NSAIDs for Dysmenorrhea Total Production Capacity (2017-2028)
1.5.2 Global NSAIDs for Dysmenorrhea Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 NSAIDs for Dysmenorrhea Market Drivers
1.6.2 NSAIDs for Dysmenorrhea Market Restraints
1.6.3 NSAIDs for Dysmenorrhea Trends Analysis
2 MANUFACTURERS PROFILES
2.1 IOLCP
2.1.1 IOLCP Details
2.1.2 IOLCP Major Business
2.1.3 IOLCP NSAIDs for Dysmenorrhea Product and Services
2.1.4 IOLCP NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Granules Biocause
2.2.1 Granules Biocause Details
2.2.2 Granules Biocause Major Business
2.2.3 Granules Biocause NSAIDs for Dysmenorrhea Product and Services
2.2.4 Granules Biocause NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Strides Shasun
2.3.1 Strides Shasun Details
2.3.2 Strides Shasun Major Business
2.3.3 Strides Shasun NSAIDs for Dysmenorrhea Product and Services
2.3.4 Strides Shasun NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 BASF
2.4.1 BASF Details
2.4.2 BASF Major Business
2.4.3 BASF NSAIDs for Dysmenorrhea Product and Services
2.4.4 BASF NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 SI Group
2.5.1 SI Group Details
2.5.2 SI Group Major Business
2.5.3 SI Group NSAIDs for Dysmenorrhea Product and Services
2.5.4 SI Group NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Hisoar
2.6.1 Hisoar Details
2.6.2 Hisoar Major Business
2.6.3 Hisoar NSAIDs for Dysmenorrhea Product and Services
2.6.4 Hisoar NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Pfizer Inc
2.7.1 Pfizer Inc Details
2.7.2 Pfizer Inc Major Business
2.7.3 Pfizer Inc NSAIDs for Dysmenorrhea Product and Services
2.7.4 Pfizer Inc NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Teva
2.8.1 Teva Details
2.8.2 Teva Major Business
2.8.3 Teva NSAIDs for Dysmenorrhea Product and Services
2.8.4 Teva NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan NSAIDs for Dysmenorrhea Product and Services
2.9.4 Mylan NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Apotex
2.10.1 Apotex Details
2.10.2 Apotex Major Business
2.10.3 Apotex NSAIDs for Dysmenorrhea Product and Services
2.10.4 Apotex NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Lupin
2.11.1 Lupin Details
2.11.2 Lupin Major Business
2.11.3 Lupin NSAIDs for Dysmenorrhea Product and Services
2.11.4 Lupin NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 SANOFI-Aventis
2.12.1 SANOFI-Aventis Details
2.12.2 SANOFI-Aventis Major Business
2.12.3 SANOFI-Aventis NSAIDs for Dysmenorrhea Product and Services
2.12.4 SANOFI-Aventis NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Boehringer-Ingelheim
2.13.1 Boehringer-Ingelheim Details
2.13.2 Boehringer-Ingelheim Major Business
2.13.3 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product and Services
2.13.4 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 BEC Chemicals
2.14.1 BEC Chemicals Details
2.14.2 BEC Chemicals Major Business
2.14.3 BEC Chemicals NSAIDs for Dysmenorrhea Product and Services
2.14.4 BEC Chemicals NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Shandong Xinhua Pharmaceutical
2.15.1 Shandong Xinhua Pharmaceutical Details
2.15.2 Shandong Xinhua Pharmaceutical Major Business
2.15.3 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
2.15.4 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Hengrui Medicine
2.16.1 Hengrui Medicine Details
2.16.2 Hengrui Medicine Major Business
2.16.3 Hengrui Medicine NSAIDs for Dysmenorrhea Product and Services
2.16.4 Hengrui Medicine NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Hubei Biocause Heilen Pharmaceutical
2.17.1 Hubei Biocause Heilen Pharmaceutical Details
2.17.2 Hubei Biocause Heilen Pharmaceutical Major Business
2.17.3 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
2.17.4 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Zibo Xinhua-PERRIGO Pharmaceutical
2.18.1 Zibo Xinhua-PERRIGO Pharmaceutical Details
2.18.2 Zibo Xinhua-PERRIGO Pharmaceutical Major Business
2.18.3 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
2.18.4 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Zhejiang Jiuzhou
2.19.1 Zhejiang Jiuzhou Details
2.19.2 Zhejiang Jiuzhou Major Business
2.19.3 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product and Services
2.19.4 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Hubei Xunda
2.20.1 Hubei Xunda Details
2.20.2 Hubei Xunda Major Business
2.20.3 Hubei Xunda NSAIDs for Dysmenorrhea Product and Services
2.20.4 Hubei Xunda NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 NSAIDS FOR DYSMENORRHEA BREAKDOWN DATA BY MANUFACTURER
3.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global NSAIDs for Dysmenorrhea Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in NSAIDs for Dysmenorrhea
3.4 Market Concentration Rate
3.4.1 Top 3 NSAIDs for Dysmenorrhea Manufacturer Market Share in 2021
3.4.2 Top 6 NSAIDs for Dysmenorrhea Manufacturer Market Share in 2021
3.5 Global NSAIDs for Dysmenorrhea Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and NSAIDs for Dysmenorrhea Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global NSAIDs for Dysmenorrhea Market Size by Region
4.1.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Region (2017-2028)
4.1.2 Global NSAIDs for Dysmenorrhea Revenue by Region (2017-2028)
4.2 North America NSAIDs for Dysmenorrhea Revenue (2017-2028)
4.3 Europe NSAIDs for Dysmenorrhea Revenue (2017-2028)
4.4 Asia-Pacific NSAIDs for Dysmenorrhea Revenue (2017-2028)
4.5 South America NSAIDs for Dysmenorrhea Revenue (2017-2028)
4.6 Middle East and Africa NSAIDs for Dysmenorrhea Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Type (2017-2028)
5.2 Global NSAIDs for Dysmenorrhea Revenue by Type (2017-2028)
5.3 Global NSAIDs for Dysmenorrhea Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Application (2017-2028)
6.2 Global NSAIDs for Dysmenorrhea Revenue by Application (2017-2028)
6.3 Global NSAIDs for Dysmenorrhea Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
7.2 North America NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
7.3 North America NSAIDs for Dysmenorrhea Market Size by Country
7.3.1 North America NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
7.3.2 North America NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
8.2 Europe NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
8.3 Europe NSAIDs for Dysmenorrhea Market Size by Country
8.3.1 Europe NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
8.3.2 Europe NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
9.2 Asia-Pacific NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
9.3 Asia-Pacific NSAIDs for Dysmenorrhea Market Size by Region
9.3.1 Asia-Pacific NSAIDs for Dysmenorrhea Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific NSAIDs for Dysmenorrhea Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
10.2 South America NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
10.3 South America NSAIDs for Dysmenorrhea Market Size by Country
10.3.1 South America NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
10.3.2 South America NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
11.2 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
11.3 Middle East & Africa NSAIDs for Dysmenorrhea Market Size by Country
11.3.1 Middle East & Africa NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of NSAIDs for Dysmenorrhea and Key Manufacturers
12.2 Manufacturing Costs Percentage of NSAIDs for Dysmenorrhea
12.3 NSAIDs for Dysmenorrhea Production Process
12.4 NSAIDs for Dysmenorrhea Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 NSAIDs for Dysmenorrhea Typical Distributors
13.3 NSAIDs for Dysmenorrhea Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 NSAIDs for Dysmenorrhea Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global NSAIDs for Dysmenorrhea Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Ibuprofen
1.2.3 Celecoxib
1.2.4 Ketoprofen
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global NSAIDs for Dysmenorrhea Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global NSAIDs for Dysmenorrhea Market Size & Forecast
1.4.1 Global NSAIDs for Dysmenorrhea Sales in Value (2017 & 2021 & 2028)
1.4.2 Global NSAIDs for Dysmenorrhea Sales in Volume (2017-2028)
1.4.3 Global NSAIDs for Dysmenorrhea Price (2017-2028)
1.5 Global NSAIDs for Dysmenorrhea Production Capacity Analysis
1.5.1 Global NSAIDs for Dysmenorrhea Total Production Capacity (2017-2028)
1.5.2 Global NSAIDs for Dysmenorrhea Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 NSAIDs for Dysmenorrhea Market Drivers
1.6.2 NSAIDs for Dysmenorrhea Market Restraints
1.6.3 NSAIDs for Dysmenorrhea Trends Analysis
2 MANUFACTURERS PROFILES
2.1 IOLCP
2.1.1 IOLCP Details
2.1.2 IOLCP Major Business
2.1.3 IOLCP NSAIDs for Dysmenorrhea Product and Services
2.1.4 IOLCP NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Granules Biocause
2.2.1 Granules Biocause Details
2.2.2 Granules Biocause Major Business
2.2.3 Granules Biocause NSAIDs for Dysmenorrhea Product and Services
2.2.4 Granules Biocause NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Strides Shasun
2.3.1 Strides Shasun Details
2.3.2 Strides Shasun Major Business
2.3.3 Strides Shasun NSAIDs for Dysmenorrhea Product and Services
2.3.4 Strides Shasun NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 BASF
2.4.1 BASF Details
2.4.2 BASF Major Business
2.4.3 BASF NSAIDs for Dysmenorrhea Product and Services
2.4.4 BASF NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 SI Group
2.5.1 SI Group Details
2.5.2 SI Group Major Business
2.5.3 SI Group NSAIDs for Dysmenorrhea Product and Services
2.5.4 SI Group NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Hisoar
2.6.1 Hisoar Details
2.6.2 Hisoar Major Business
2.6.3 Hisoar NSAIDs for Dysmenorrhea Product and Services
2.6.4 Hisoar NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Pfizer Inc
2.7.1 Pfizer Inc Details
2.7.2 Pfizer Inc Major Business
2.7.3 Pfizer Inc NSAIDs for Dysmenorrhea Product and Services
2.7.4 Pfizer Inc NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Teva
2.8.1 Teva Details
2.8.2 Teva Major Business
2.8.3 Teva NSAIDs for Dysmenorrhea Product and Services
2.8.4 Teva NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan NSAIDs for Dysmenorrhea Product and Services
2.9.4 Mylan NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Apotex
2.10.1 Apotex Details
2.10.2 Apotex Major Business
2.10.3 Apotex NSAIDs for Dysmenorrhea Product and Services
2.10.4 Apotex NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Lupin
2.11.1 Lupin Details
2.11.2 Lupin Major Business
2.11.3 Lupin NSAIDs for Dysmenorrhea Product and Services
2.11.4 Lupin NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 SANOFI-Aventis
2.12.1 SANOFI-Aventis Details
2.12.2 SANOFI-Aventis Major Business
2.12.3 SANOFI-Aventis NSAIDs for Dysmenorrhea Product and Services
2.12.4 SANOFI-Aventis NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Boehringer-Ingelheim
2.13.1 Boehringer-Ingelheim Details
2.13.2 Boehringer-Ingelheim Major Business
2.13.3 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product and Services
2.13.4 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 BEC Chemicals
2.14.1 BEC Chemicals Details
2.14.2 BEC Chemicals Major Business
2.14.3 BEC Chemicals NSAIDs for Dysmenorrhea Product and Services
2.14.4 BEC Chemicals NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Shandong Xinhua Pharmaceutical
2.15.1 Shandong Xinhua Pharmaceutical Details
2.15.2 Shandong Xinhua Pharmaceutical Major Business
2.15.3 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
2.15.4 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Hengrui Medicine
2.16.1 Hengrui Medicine Details
2.16.2 Hengrui Medicine Major Business
2.16.3 Hengrui Medicine NSAIDs for Dysmenorrhea Product and Services
2.16.4 Hengrui Medicine NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Hubei Biocause Heilen Pharmaceutical
2.17.1 Hubei Biocause Heilen Pharmaceutical Details
2.17.2 Hubei Biocause Heilen Pharmaceutical Major Business
2.17.3 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
2.17.4 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Zibo Xinhua-PERRIGO Pharmaceutical
2.18.1 Zibo Xinhua-PERRIGO Pharmaceutical Details
2.18.2 Zibo Xinhua-PERRIGO Pharmaceutical Major Business
2.18.3 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
2.18.4 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Zhejiang Jiuzhou
2.19.1 Zhejiang Jiuzhou Details
2.19.2 Zhejiang Jiuzhou Major Business
2.19.3 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product and Services
2.19.4 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Hubei Xunda
2.20.1 Hubei Xunda Details
2.20.2 Hubei Xunda Major Business
2.20.3 Hubei Xunda NSAIDs for Dysmenorrhea Product and Services
2.20.4 Hubei Xunda NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 NSAIDS FOR DYSMENORRHEA BREAKDOWN DATA BY MANUFACTURER
3.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global NSAIDs for Dysmenorrhea Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in NSAIDs for Dysmenorrhea
3.4 Market Concentration Rate
3.4.1 Top 3 NSAIDs for Dysmenorrhea Manufacturer Market Share in 2021
3.4.2 Top 6 NSAIDs for Dysmenorrhea Manufacturer Market Share in 2021
3.5 Global NSAIDs for Dysmenorrhea Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and NSAIDs for Dysmenorrhea Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global NSAIDs for Dysmenorrhea Market Size by Region
4.1.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Region (2017-2028)
4.1.2 Global NSAIDs for Dysmenorrhea Revenue by Region (2017-2028)
4.2 North America NSAIDs for Dysmenorrhea Revenue (2017-2028)
4.3 Europe NSAIDs for Dysmenorrhea Revenue (2017-2028)
4.4 Asia-Pacific NSAIDs for Dysmenorrhea Revenue (2017-2028)
4.5 South America NSAIDs for Dysmenorrhea Revenue (2017-2028)
4.6 Middle East and Africa NSAIDs for Dysmenorrhea Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Type (2017-2028)
5.2 Global NSAIDs for Dysmenorrhea Revenue by Type (2017-2028)
5.3 Global NSAIDs for Dysmenorrhea Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Application (2017-2028)
6.2 Global NSAIDs for Dysmenorrhea Revenue by Application (2017-2028)
6.3 Global NSAIDs for Dysmenorrhea Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
7.2 North America NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
7.3 North America NSAIDs for Dysmenorrhea Market Size by Country
7.3.1 North America NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
7.3.2 North America NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
8.2 Europe NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
8.3 Europe NSAIDs for Dysmenorrhea Market Size by Country
8.3.1 Europe NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
8.3.2 Europe NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
9.2 Asia-Pacific NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
9.3 Asia-Pacific NSAIDs for Dysmenorrhea Market Size by Region
9.3.1 Asia-Pacific NSAIDs for Dysmenorrhea Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific NSAIDs for Dysmenorrhea Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
10.2 South America NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
10.3 South America NSAIDs for Dysmenorrhea Market Size by Country
10.3.1 South America NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
10.3.2 South America NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
11.2 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
11.3 Middle East & Africa NSAIDs for Dysmenorrhea Market Size by Country
11.3.1 Middle East & Africa NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of NSAIDs for Dysmenorrhea and Key Manufacturers
12.2 Manufacturing Costs Percentage of NSAIDs for Dysmenorrhea
12.3 NSAIDs for Dysmenorrhea Production Process
12.4 NSAIDs for Dysmenorrhea Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 NSAIDs for Dysmenorrhea Typical Distributors
13.3 NSAIDs for Dysmenorrhea Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global NSAIDs for Dysmenorrhea Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global NSAIDs for Dysmenorrhea Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. IOLCP Basic Information, Manufacturing Base and Competitors
Table 4. IOLCP Major Business
Table 5. IOLCP NSAIDs for Dysmenorrhea Product and Services
Table 6. IOLCP NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Granules Biocause Basic Information, Manufacturing Base and Competitors
Table 8. Granules Biocause Major Business
Table 9. Granules Biocause NSAIDs for Dysmenorrhea Product and Services
Table 10. Granules Biocause NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Strides Shasun Basic Information, Manufacturing Base and Competitors
Table 12. Strides Shasun Major Business
Table 13. Strides Shasun NSAIDs for Dysmenorrhea Product and Services
Table 14. Strides Shasun NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. BASF Basic Information, Manufacturing Base and Competitors
Table 16. BASF Major Business
Table 17. BASF NSAIDs for Dysmenorrhea Product and Services
Table 18. BASF NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. SI Group Basic Information, Manufacturing Base and Competitors
Table 20. SI Group Major Business
Table 21. SI Group NSAIDs for Dysmenorrhea Product and Services
Table 22. SI Group NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Hisoar Basic Information, Manufacturing Base and Competitors
Table 24. Hisoar Major Business
Table 25. Hisoar NSAIDs for Dysmenorrhea Product and Services
Table 26. Hisoar NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Inc Major Business
Table 29. Pfizer Inc NSAIDs for Dysmenorrhea Product and Services
Table 30. Pfizer Inc NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Teva Basic Information, Manufacturing Base and Competitors
Table 32. Teva Major Business
Table 33. Teva NSAIDs for Dysmenorrhea Product and Services
Table 34. Teva NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Mylan Basic Information, Manufacturing Base and Competitors
Table 36. Mylan Major Business
Table 37. Mylan NSAIDs for Dysmenorrhea Product and Services
Table 38. Mylan NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Apotex Basic Information, Manufacturing Base and Competitors
Table 40. Apotex Major Business
Table 41. Apotex NSAIDs for Dysmenorrhea Product and Services
Table 42. Apotex NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Lupin Basic Information, Manufacturing Base and Competitors
Table 44. Lupin Major Business
Table 45. Lupin NSAIDs for Dysmenorrhea Product and Services
Table 46. Lupin NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. SANOFI-Aventis Basic Information, Manufacturing Base and Competitors
Table 48. SANOFI-Aventis Major Business
Table 49. SANOFI-Aventis NSAIDs for Dysmenorrhea Product and Services
Table 50. SANOFI-Aventis NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 52. Boehringer-Ingelheim Major Business
Table 53. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product and Services
Table 54. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. BEC Chemicals Basic Information, Manufacturing Base and Competitors
Table 56. BEC Chemicals Major Business
Table 57. BEC Chemicals NSAIDs for Dysmenorrhea Product and Services
Table 58. BEC Chemicals NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Shandong Xinhua Pharmaceutical Major Business
Table 61. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
Table 62. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 64. Hengrui Medicine Major Business
Table 65. Hengrui Medicine NSAIDs for Dysmenorrhea Product and Services
Table 66. Hengrui Medicine NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Hubei Biocause Heilen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Hubei Biocause Heilen Pharmaceutical Major Business
Table 69. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
Table 70. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Zibo Xinhua-PERRIGO Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Zibo Xinhua-PERRIGO Pharmaceutical Major Business
Table 73. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
Table 74. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Zhejiang Jiuzhou Basic Information, Manufacturing Base and Competitors
Table 76. Zhejiang Jiuzhou Major Business
Table 77. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product and Services
Table 78. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Hubei Xunda Basic Information, Manufacturing Base and Competitors
Table 80. Hubei Xunda Major Business
Table 81. Hubei Xunda NSAIDs for Dysmenorrhea Product and Services
Table 82. Hubei Xunda NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global NSAIDs for Dysmenorrhea Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 84. Global NSAIDs for Dysmenorrhea Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in NSAIDs for Dysmenorrhea, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global NSAIDs for Dysmenorrhea Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and NSAIDs for Dysmenorrhea Production Site of Key Manufacturer
Table 88. NSAIDs for Dysmenorrhea New Entrant and Capacity Expansion Plans
Table 89. NSAIDs for Dysmenorrhea Mergers & Acquisitions in the Past Five Years
Table 90. Global NSAIDs for Dysmenorrhea Sales by Region (2017-2022) & (K Units)
Table 91. Global NSAIDs for Dysmenorrhea Sales by Region (2023-2028) & (K Units)
Table 92. Global NSAIDs for Dysmenorrhea Revenue by Region (2017-2022) & (USD Million)
Table 93. Global NSAIDs for Dysmenorrhea Revenue by Region (2023-2028) & (USD Million)
Table 94. Global NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 95. Global NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 96. Global NSAIDs for Dysmenorrhea Revenue by Type (2017-2022) & (USD Million)
Table 97. Global NSAIDs for Dysmenorrhea Revenue by Type (2023-2028) & (USD Million)
Table 98. Global NSAIDs for Dysmenorrhea Price by Type (2017-2022) & (US$/Unit)
Table 99. Global NSAIDs for Dysmenorrhea Price by Type (2023-2028) & (US$/Unit)
Table 100. Global NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 101. Global NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 102. Global NSAIDs for Dysmenorrhea Revenue by Application (2017-2022) & (USD Million)
Table 103. Global NSAIDs for Dysmenorrhea Revenue by Application (2023-2028) & (USD Million)
Table 104. Global NSAIDs for Dysmenorrhea Price by Application (2017-2022) & (US$/Unit)
Table 105. Global NSAIDs for Dysmenorrhea Price by Application (2023-2028) & (US$/Unit)
Table 106. North America NSAIDs for Dysmenorrhea Sales by Country (2017-2022) & (K Units)
Table 107. North America NSAIDs for Dysmenorrhea Sales by Country (2023-2028) & (K Units)
Table 108. North America NSAIDs for Dysmenorrhea Revenue by Country (2017-2022) & (USD Million)
Table 109. North America NSAIDs for Dysmenorrhea Revenue by Country (2023-2028) & (USD Million)
Table 110. North America NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 111. North America NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 112. North America NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 113. North America NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 114. Europe NSAIDs for Dysmenorrhea Sales by Country (2017-2022) & (K Units)
Table 115. Europe NSAIDs for Dysmenorrhea Sales by Country (2023-2028) & (K Units)
Table 116. Europe NSAIDs for Dysmenorrhea Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe NSAIDs for Dysmenorrhea Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 119. Europe NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 120. Europe NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 121. Europe NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 122. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Region (2017-2022) & (K Units)
Table 123. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Region (2023-2028) & (K Units)
Table 124. Asia-Pacific NSAIDs for Dysmenorrhea Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific NSAIDs for Dysmenorrhea Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 127. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 128. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 129. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 130. South America NSAIDs for Dysmenorrhea Sales by Country (2017-2022) & (K Units)
Table 131. South America NSAIDs for Dysmenorrhea Sales by Country (2023-2028) & (K Units)
Table 132. South America NSAIDs for Dysmenorrhea Revenue by Country (2017-2022) & (USD Million)
Table 133. South America NSAIDs for Dysmenorrhea Revenue by Country (2023-2028) & (USD Million)
Table 134. South America NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 135. South America NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 136. South America NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 137. South America NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 138. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Region (2017-2022) & (K Units)
Table 139. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Region (2023-2028) & (K Units)
Table 140. Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 143. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 144. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 145. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 146. NSAIDs for Dysmenorrhea Raw Material
Table 147. Key Manufacturers of NSAIDs for Dysmenorrhea Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. NSAIDs for Dysmenorrhea Typical Distributors
Table 151. NSAIDs for Dysmenorrhea Typical Customers
Table 1. Global NSAIDs for Dysmenorrhea Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global NSAIDs for Dysmenorrhea Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. IOLCP Basic Information, Manufacturing Base and Competitors
Table 4. IOLCP Major Business
Table 5. IOLCP NSAIDs for Dysmenorrhea Product and Services
Table 6. IOLCP NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Granules Biocause Basic Information, Manufacturing Base and Competitors
Table 8. Granules Biocause Major Business
Table 9. Granules Biocause NSAIDs for Dysmenorrhea Product and Services
Table 10. Granules Biocause NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Strides Shasun Basic Information, Manufacturing Base and Competitors
Table 12. Strides Shasun Major Business
Table 13. Strides Shasun NSAIDs for Dysmenorrhea Product and Services
Table 14. Strides Shasun NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. BASF Basic Information, Manufacturing Base and Competitors
Table 16. BASF Major Business
Table 17. BASF NSAIDs for Dysmenorrhea Product and Services
Table 18. BASF NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. SI Group Basic Information, Manufacturing Base and Competitors
Table 20. SI Group Major Business
Table 21. SI Group NSAIDs for Dysmenorrhea Product and Services
Table 22. SI Group NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Hisoar Basic Information, Manufacturing Base and Competitors
Table 24. Hisoar Major Business
Table 25. Hisoar NSAIDs for Dysmenorrhea Product and Services
Table 26. Hisoar NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Inc Major Business
Table 29. Pfizer Inc NSAIDs for Dysmenorrhea Product and Services
Table 30. Pfizer Inc NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Teva Basic Information, Manufacturing Base and Competitors
Table 32. Teva Major Business
Table 33. Teva NSAIDs for Dysmenorrhea Product and Services
Table 34. Teva NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Mylan Basic Information, Manufacturing Base and Competitors
Table 36. Mylan Major Business
Table 37. Mylan NSAIDs for Dysmenorrhea Product and Services
Table 38. Mylan NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Apotex Basic Information, Manufacturing Base and Competitors
Table 40. Apotex Major Business
Table 41. Apotex NSAIDs for Dysmenorrhea Product and Services
Table 42. Apotex NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Lupin Basic Information, Manufacturing Base and Competitors
Table 44. Lupin Major Business
Table 45. Lupin NSAIDs for Dysmenorrhea Product and Services
Table 46. Lupin NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. SANOFI-Aventis Basic Information, Manufacturing Base and Competitors
Table 48. SANOFI-Aventis Major Business
Table 49. SANOFI-Aventis NSAIDs for Dysmenorrhea Product and Services
Table 50. SANOFI-Aventis NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 52. Boehringer-Ingelheim Major Business
Table 53. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product and Services
Table 54. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. BEC Chemicals Basic Information, Manufacturing Base and Competitors
Table 56. BEC Chemicals Major Business
Table 57. BEC Chemicals NSAIDs for Dysmenorrhea Product and Services
Table 58. BEC Chemicals NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Shandong Xinhua Pharmaceutical Major Business
Table 61. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
Table 62. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 64. Hengrui Medicine Major Business
Table 65. Hengrui Medicine NSAIDs for Dysmenorrhea Product and Services
Table 66. Hengrui Medicine NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Hubei Biocause Heilen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Hubei Biocause Heilen Pharmaceutical Major Business
Table 69. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
Table 70. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Zibo Xinhua-PERRIGO Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Zibo Xinhua-PERRIGO Pharmaceutical Major Business
Table 73. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
Table 74. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Zhejiang Jiuzhou Basic Information, Manufacturing Base and Competitors
Table 76. Zhejiang Jiuzhou Major Business
Table 77. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product and Services
Table 78. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Hubei Xunda Basic Information, Manufacturing Base and Competitors
Table 80. Hubei Xunda Major Business
Table 81. Hubei Xunda NSAIDs for Dysmenorrhea Product and Services
Table 82. Hubei Xunda NSAIDs for Dysmenorrhea Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global NSAIDs for Dysmenorrhea Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 84. Global NSAIDs for Dysmenorrhea Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in NSAIDs for Dysmenorrhea, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global NSAIDs for Dysmenorrhea Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and NSAIDs for Dysmenorrhea Production Site of Key Manufacturer
Table 88. NSAIDs for Dysmenorrhea New Entrant and Capacity Expansion Plans
Table 89. NSAIDs for Dysmenorrhea Mergers & Acquisitions in the Past Five Years
Table 90. Global NSAIDs for Dysmenorrhea Sales by Region (2017-2022) & (K Units)
Table 91. Global NSAIDs for Dysmenorrhea Sales by Region (2023-2028) & (K Units)
Table 92. Global NSAIDs for Dysmenorrhea Revenue by Region (2017-2022) & (USD Million)
Table 93. Global NSAIDs for Dysmenorrhea Revenue by Region (2023-2028) & (USD Million)
Table 94. Global NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 95. Global NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 96. Global NSAIDs for Dysmenorrhea Revenue by Type (2017-2022) & (USD Million)
Table 97. Global NSAIDs for Dysmenorrhea Revenue by Type (2023-2028) & (USD Million)
Table 98. Global NSAIDs for Dysmenorrhea Price by Type (2017-2022) & (US$/Unit)
Table 99. Global NSAIDs for Dysmenorrhea Price by Type (2023-2028) & (US$/Unit)
Table 100. Global NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 101. Global NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 102. Global NSAIDs for Dysmenorrhea Revenue by Application (2017-2022) & (USD Million)
Table 103. Global NSAIDs for Dysmenorrhea Revenue by Application (2023-2028) & (USD Million)
Table 104. Global NSAIDs for Dysmenorrhea Price by Application (2017-2022) & (US$/Unit)
Table 105. Global NSAIDs for Dysmenorrhea Price by Application (2023-2028) & (US$/Unit)
Table 106. North America NSAIDs for Dysmenorrhea Sales by Country (2017-2022) & (K Units)
Table 107. North America NSAIDs for Dysmenorrhea Sales by Country (2023-2028) & (K Units)
Table 108. North America NSAIDs for Dysmenorrhea Revenue by Country (2017-2022) & (USD Million)
Table 109. North America NSAIDs for Dysmenorrhea Revenue by Country (2023-2028) & (USD Million)
Table 110. North America NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 111. North America NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 112. North America NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 113. North America NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 114. Europe NSAIDs for Dysmenorrhea Sales by Country (2017-2022) & (K Units)
Table 115. Europe NSAIDs for Dysmenorrhea Sales by Country (2023-2028) & (K Units)
Table 116. Europe NSAIDs for Dysmenorrhea Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe NSAIDs for Dysmenorrhea Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 119. Europe NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 120. Europe NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 121. Europe NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 122. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Region (2017-2022) & (K Units)
Table 123. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Region (2023-2028) & (K Units)
Table 124. Asia-Pacific NSAIDs for Dysmenorrhea Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific NSAIDs for Dysmenorrhea Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 127. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 128. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 129. Asia-Pacific NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 130. South America NSAIDs for Dysmenorrhea Sales by Country (2017-2022) & (K Units)
Table 131. South America NSAIDs for Dysmenorrhea Sales by Country (2023-2028) & (K Units)
Table 132. South America NSAIDs for Dysmenorrhea Revenue by Country (2017-2022) & (USD Million)
Table 133. South America NSAIDs for Dysmenorrhea Revenue by Country (2023-2028) & (USD Million)
Table 134. South America NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 135. South America NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 136. South America NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 137. South America NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 138. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Region (2017-2022) & (K Units)
Table 139. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Region (2023-2028) & (K Units)
Table 140. Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 143. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Type (2023-2028) & (K Units)
Table 144. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 145. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Application (2023-2028) & (K Units)
Table 146. NSAIDs for Dysmenorrhea Raw Material
Table 147. Key Manufacturers of NSAIDs for Dysmenorrhea Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. NSAIDs for Dysmenorrhea Typical Distributors
Table 151. NSAIDs for Dysmenorrhea Typical Customers
LIST OF FIGURES
Figure 1. NSAIDs for Dysmenorrhea Picture
Figure 2. Global NSAIDs for Dysmenorrhea Revenue Market Share by Type in 2021
Figure 3. Ibuprofen
Figure 4. Celecoxib
Figure 5. Ketoprofen
Figure 6. Others
Figure 7. Global NSAIDs for Dysmenorrhea Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Global NSAIDs for Dysmenorrhea Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global NSAIDs for Dysmenorrhea Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global NSAIDs for Dysmenorrhea Sales (2017-2028) & (K Units)
Figure 15. Global NSAIDs for Dysmenorrhea Price (2017-2028) & (US$/Unit)
Figure 16. Global NSAIDs for Dysmenorrhea Production Capacity (2017-2028) & (K Units)
Figure 17. Global NSAIDs for Dysmenorrhea Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. NSAIDs for Dysmenorrhea Market Drivers
Figure 19. NSAIDs for Dysmenorrhea Market Restraints
Figure 20. NSAIDs for Dysmenorrhea Market Trends
Figure 21. Global NSAIDs for Dysmenorrhea Sales Market Share by Manufacturer in 2021
Figure 22. Global NSAIDs for Dysmenorrhea Revenue Market Share by Manufacturer in 2021
Figure 23. NSAIDs for Dysmenorrhea Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 NSAIDs for Dysmenorrhea Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 NSAIDs for Dysmenorrhea Manufacturer (Revenue) Market Share in 2021
Figure 26. Global NSAIDs for Dysmenorrhea Sales Market Share by Region (2017-2028)
Figure 27. Global NSAIDs for Dysmenorrhea Revenue Market Share by Region (2017-2028)
Figure 28. North America NSAIDs for Dysmenorrhea Revenue (2017-2028) & (USD Million)
Figure 29. Europe NSAIDs for Dysmenorrhea Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific NSAIDs for Dysmenorrhea Revenue (2017-2028) & (USD Million)
Figure 31. South America NSAIDs for Dysmenorrhea Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa NSAIDs for Dysmenorrhea Revenue (2017-2028) & (USD Million)
Figure 33. Global NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2028)
Figure 34. Global NSAIDs for Dysmenorrhea Revenue Market Share by Type (2017-2028)
Figure 35. Global NSAIDs for Dysmenorrhea Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 37. Global NSAIDs for Dysmenorrhea Revenue Market Share by Application (2017-2028)
Figure 38. Global NSAIDs for Dysmenorrhea Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2028)
Figure 40. North America NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 41. North America NSAIDs for Dysmenorrhea Sales Market Share by Country (2017-2028)
Figure 42. North America NSAIDs for Dysmenorrhea Revenue Market Share by Country (2017-2028)
Figure 43. United States NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2028)
Figure 47. Europe NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 48. Europe NSAIDs for Dysmenorrhea Sales Market Share by Country (2017-2028)
Figure 49. Europe NSAIDs for Dysmenorrhea Revenue Market Share by Country (2017-2028)
Figure 50. Germany NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific NSAIDs for Dysmenorrhea Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific NSAIDs for Dysmenorrhea Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific NSAIDs for Dysmenorrhea Revenue Market Share by Region (2017-2028)
Figure 59. China NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2028)
Figure 66. South America NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 67. South America NSAIDs for Dysmenorrhea Sales Market Share by Country (2017-2028)
Figure 68. South America NSAIDs for Dysmenorrhea Revenue Market Share by Country (2017-2028)
Figure 69. Brazil NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa NSAIDs for Dysmenorrhea Revenue Market Share by Region (2017-2028)
Figure 75. Turkey NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of NSAIDs for Dysmenorrhea in 2021
Figure 80. Manufacturing Process Analysis of NSAIDs for Dysmenorrhea
Figure 81. NSAIDs for Dysmenorrhea Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. NSAIDs for Dysmenorrhea Picture
Figure 2. Global NSAIDs for Dysmenorrhea Revenue Market Share by Type in 2021
Figure 3. Ibuprofen
Figure 4. Celecoxib
Figure 5. Ketoprofen
Figure 6. Others
Figure 7. Global NSAIDs for Dysmenorrhea Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Global NSAIDs for Dysmenorrhea Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global NSAIDs for Dysmenorrhea Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global NSAIDs for Dysmenorrhea Sales (2017-2028) & (K Units)
Figure 15. Global NSAIDs for Dysmenorrhea Price (2017-2028) & (US$/Unit)
Figure 16. Global NSAIDs for Dysmenorrhea Production Capacity (2017-2028) & (K Units)
Figure 17. Global NSAIDs for Dysmenorrhea Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. NSAIDs for Dysmenorrhea Market Drivers
Figure 19. NSAIDs for Dysmenorrhea Market Restraints
Figure 20. NSAIDs for Dysmenorrhea Market Trends
Figure 21. Global NSAIDs for Dysmenorrhea Sales Market Share by Manufacturer in 2021
Figure 22. Global NSAIDs for Dysmenorrhea Revenue Market Share by Manufacturer in 2021
Figure 23. NSAIDs for Dysmenorrhea Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 NSAIDs for Dysmenorrhea Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 NSAIDs for Dysmenorrhea Manufacturer (Revenue) Market Share in 2021
Figure 26. Global NSAIDs for Dysmenorrhea Sales Market Share by Region (2017-2028)
Figure 27. Global NSAIDs for Dysmenorrhea Revenue Market Share by Region (2017-2028)
Figure 28. North America NSAIDs for Dysmenorrhea Revenue (2017-2028) & (USD Million)
Figure 29. Europe NSAIDs for Dysmenorrhea Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific NSAIDs for Dysmenorrhea Revenue (2017-2028) & (USD Million)
Figure 31. South America NSAIDs for Dysmenorrhea Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa NSAIDs for Dysmenorrhea Revenue (2017-2028) & (USD Million)
Figure 33. Global NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2028)
Figure 34. Global NSAIDs for Dysmenorrhea Revenue Market Share by Type (2017-2028)
Figure 35. Global NSAIDs for Dysmenorrhea Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 37. Global NSAIDs for Dysmenorrhea Revenue Market Share by Application (2017-2028)
Figure 38. Global NSAIDs for Dysmenorrhea Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2028)
Figure 40. North America NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 41. North America NSAIDs for Dysmenorrhea Sales Market Share by Country (2017-2028)
Figure 42. North America NSAIDs for Dysmenorrhea Revenue Market Share by Country (2017-2028)
Figure 43. United States NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2028)
Figure 47. Europe NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 48. Europe NSAIDs for Dysmenorrhea Sales Market Share by Country (2017-2028)
Figure 49. Europe NSAIDs for Dysmenorrhea Revenue Market Share by Country (2017-2028)
Figure 50. Germany NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific NSAIDs for Dysmenorrhea Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific NSAIDs for Dysmenorrhea Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific NSAIDs for Dysmenorrhea Revenue Market Share by Region (2017-2028)
Figure 59. China NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2028)
Figure 66. South America NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 67. South America NSAIDs for Dysmenorrhea Sales Market Share by Country (2017-2028)
Figure 68. South America NSAIDs for Dysmenorrhea Revenue Market Share by Country (2017-2028)
Figure 69. Brazil NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa NSAIDs for Dysmenorrhea Revenue Market Share by Region (2017-2028)
Figure 75. Turkey NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa NSAIDs for Dysmenorrhea Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of NSAIDs for Dysmenorrhea in 2021
Figure 80. Manufacturing Process Analysis of NSAIDs for Dysmenorrhea
Figure 81. NSAIDs for Dysmenorrhea Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
